Abdelhakim Lakhdar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abdelhakim Lakhdar has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Hicham El Otmani
Neurology Department, Ibn Rochd University Hospital Center, Casablanca, Morocco
6 shared publications - Mohamed Daghi
Research Laboratory of Nervous System Diseases, Neurosensory Disorders & Disability, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco
6 shared publications Khadija Ibahioin
Service de Neurochirurgie, Centre Hospitalier Universitaire Ibn Rochd, Casablanca, Maroc
2 shared publications- Nadia Tahiri Jouti
Laboratory of Cellular and Molecular Inflammatory, Degenerative and Oncologic Pathophysiology, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco
2 shared publications Abderrazak Bertal
Service de Neurochirurgie, Centre Hospitalier Universitaire Ibn Rochd, Casablanca, Maroc
1 shared publicationAmine El Khaoudi
Anaesthesiology unit, Department of Obstetrics and Gynaecology, Ibn Rochd University Hospital, Casablanca, Morocco
1 shared publication
Latest Publications
- Open Access
- 18 September 2025
- Published by SAGE Publications in Journal of Patient Experience
- Vol. 12
Knowledge of Parkinson's Disease, Perceptions of Deep Brain Stimulation, and Attitudes Toward Its Use Among Patients in Morocco: A Cross-Sectional Study
Parkinson's disease (PD) is a chronic neurodegenerative disorder requiring informed decision making, especially regarding advanced treatments such as deep brain stimulation (DBS). However, patient knowledge and perceptions in low-resource settings like Morocco remain poorly understood. This study assessed PD patients’ knowledge and attitudes/perceptions toward DBS in Morocco. A cross-sectional study was conducted among PD patients in 5 cities in the Casablanca-Settat region. Data were collected using a 7-item PD knowledge tool and a DBS attitudes/perceptions questionnaire. A total of 370 patients were recruited, with a mean PD knowledge score of 4.5 out of 7, with higher scores linked to greater education. Only 31.9% had heard of DBS, and 39.4% were willing to undergo it if recommended. Willingness was higher among patients from the private sector, those with longer disease duration, and those at advanced stages. A common misconception was that DBS cures PD (25.9%). Barriers to DBS access included high cost, fear of surgery, lack of specialists, and insufficient information. Gaps in PD knowledge and misconceptions about DBS persist, highlighting the need for targeted educational initiatives in Morocco.
- 18 September 2025
- Published by SAGE Publications in Journal of Patient Experience
- Vol. 12
Open AccessKnowledge of Parkinson's Disease, Perceptions of Deep Brain Stimulation, and Attitudes Toward Its Use Among Patients in Morocco: A Cross-Sectional Study
Parkinson's disease (PD) is a chronic neurodegenerative disorder requiring informed decision making, especially regarding advanced treatments such as deep brain stimulation (DBS). However, patient knowledge and perceptions in low-resource settings like Morocco remain poorly understood. This study assessed PD patients’ knowledge and attitudes/perceptions toward DBS in Morocco. A cross-sectional study was conducted among PD patients in 5 cities in the Casablanca-Settat region. Data were collected using a 7-item PD knowledge tool and a DBS attitudes/perceptions questionnaire. A total of 370 patients were recruited, with a mean PD knowledge score of 4.5 out of 7, with higher scores linked to greater education. Only 31.9% had heard of DBS, and 39.4% were willing to undergo it if recommended. Willingness was higher among patients from the private sector, those with longer disease duration, and those at advanced stages. A common misconception was that DBS cures PD (25.9%). Barriers to DBS access included high cost, fear of surgery, lack of specialists, and insufficient information. Gaps in PD knowledge and misconceptions about DBS persist, highlighting the need for targeted educational initiatives in Morocco.
- Open Access
- 1 September 2025
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 16 (5) , 941-948
Subthalamic Nucleus Deep Brain Stimulation in Early-onset Parkinson’s Disease: Clinical Outcomes in LRRK2 Mutation Carriers Compared to Non-Carriers
Introduction: Subthalamic nucleus deep brain stimulation (STN-DBS) is an established treatment for early-onset Parkinson’s disease (EOPD). While the effect of STN-DBS on patients with LRRK2 G2019S mutation has been largely investigated, data specific to EOPD patients with this mutation remain scarce. This study examines the impact of the LRRK2 G2019S ...
- 1 September 2025
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 16 (5) , 941-948
Open AccessSubthalamic Nucleus Deep Brain Stimulation in Early-onset Parkinson’s Disease: Clinical Outcomes in LRRK2 Mutation Carriers Compared to Non-Carriers
Introduction: Subthalamic nucleus deep brain stimulation (STN-DBS) is an established treatment for early-onset Parkinson’s disease (EOPD). While the effect of STN-DBS on patients with LRRK2 G2019S mutation has been largely investigated, data specific to EOPD patients with this mutation remain scarce. This study examines the impact of the LRRK2 G2019S ...
- 24 March 2025
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 15 (2-3) , 65-76
Advanced Parkinson’s disease and eligibility for device-aided therapies in Morocco: a multicenter cross-sectional study
This study investigates the prevalence and clinical features of advanced Parkinson's disease (APD) in Moroccan patients and evaluates their eligibility for Device-Aided Therapies (DATs), including Deep Brain Stimulation (DBS), Continuous Subcutaneous Apomorphine Infusion (CSAI), and Levodopa-Carbidopa Intestinal Gel infusion (LCIG). We conducted a cross-sectional study across 15 facilities in five cities within the Casablanca-Settat region, Morocco. We collected demographics, clinical, and health-related quality of life data. Logistic regression identified factors predicting disease progression and DATs eligibility. This study included 370 patients with Parkinson's disease, of whom 44.6% (95%CI: 39.5%-49.8%) had APD. Each additional year of disease duration increased APD odds by 8% (ORa = 1.08, p = 0.047). Overall, 38.9% of patients qualified for at least one DAT, including 18.9% for DBS, 35.4% for CSAI, and 13.8% for LCIG; however, only one patient received DBS. Younger age at onset was associated with greater DATs eligibility, with each additional year reducing eligibility by 7% (ORa = 0.93, p < 0.001). Additionally, premotor REM sleep behavior disorder increased the odds of LCIG eligibility (ORa = 2.38, p = 0.009), while prior sports engagement nearly tripled the odds for CSAI (ORa = 2.87, p = 0.038). Although many Moroccan patients qualify for DATs, their use is minimal. Addressing access barriers is crucial to improve outcomes.
- 24 March 2025
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 15 (2-3) , 65-76
Advanced Parkinson’s disease and eligibility for device-aided therapies in Morocco: a multicenter cross-sectional study
This study investigates the prevalence and clinical features of advanced Parkinson's disease (APD) in Moroccan patients and evaluates their eligibility for Device-Aided Therapies (DATs), including Deep Brain Stimulation (DBS), Continuous Subcutaneous Apomorphine Infusion (CSAI), and Levodopa-Carbidopa Intestinal Gel infusion (LCIG). We conducted a cross-sectional study across 15 facilities in five cities within the Casablanca-Settat region, Morocco. We collected demographics, clinical, and health-related quality of life data. Logistic regression identified factors predicting disease progression and DATs eligibility. This study included 370 patients with Parkinson's disease, of whom 44.6% (95%CI: 39.5%-49.8%) had APD. Each additional year of disease duration increased APD odds by 8% (ORa = 1.08, p = 0.047). Overall, 38.9% of patients qualified for at least one DAT, including 18.9% for DBS, 35.4% for CSAI, and 13.8% for LCIG; however, only one patient received DBS. Younger age at onset was associated with greater DATs eligibility, with each additional year reducing eligibility by 7% (ORa = 0.93, p < 0.001). Additionally, premotor REM sleep behavior disorder increased the odds of LCIG eligibility (ORa = 2.38, p = 0.009), while prior sports engagement nearly tripled the odds for CSAI (ORa = 2.87, p = 0.038). Although many Moroccan patients qualify for DATs, their use is minimal. Addressing access barriers is crucial to improve outcomes.
- Open Access
- 31 January 2025
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 18 (1) , 106-107
Barriers to Accessing Deep Brain Stimulation for Parkinson’s Disease Patients in Morocco
Barriers to Accessing Deep Brain Stimulation for Parkinson’s Disease Patients in Morocco
- 31 January 2025
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 18 (1) , 106-107
Open AccessBarriers to Accessing Deep Brain Stimulation for Parkinson’s Disease Patients in Morocco
Barriers to Accessing Deep Brain Stimulation for Parkinson’s Disease Patients in Morocco
- 21 February 2023
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 13 (2) , 129-139
Parkinson’s Disease Research in Morocco: A Review
Aim: To quantify and provide an overview on the scientific productivity made by Moroccan academics in the research on Parkinson's disease (PD) and parkinsonism. Materials & methods: Scientific arti... Plain language summary This work aims to quantify the studies conducted by Moroccan academics on Parkinson's disease (PD), which is a neurological condition that causes shaking, muscle stiffness an...
- 21 February 2023
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 13 (2) , 129-139
Parkinson’s Disease Research in Morocco: A Review
Aim: To quantify and provide an overview on the scientific productivity made by Moroccan academics in the research on Parkinson's disease (PD) and parkinsonism. Materials & methods: Scientific arti... Plain language summary This work aims to quantify the studies conducted by Moroccan academics on Parkinson's disease (PD), which is a neurological condition that causes shaking, muscle stiffness an...
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Clinical Neurology
- Vol. 19 (5) , 501-502
Severe and Reversible Exacerbation of Primary Dystonia Associated With Hypothyroidism
El Otmani H, et al. J Clin Neurol. 2023 Sep;19(5):501-502. https://doi.org/10.3988/jcn.2023.0050
- 1 January 2023
- Published by XMLink in Journal of Clinical Neurology
- Vol. 19 (5) , 501-502
Open AccessSevere and Reversible Exacerbation of Primary Dystonia Associated With Hypothyroidism
El Otmani H, et al. J Clin Neurol. 2023 Sep;19(5):501-502. https://doi.org/10.3988/jcn.2023.0050
- Open Access
- 1 January 2020
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 36, 160
Ostéoblastome de l´os pariétal de la voute du crâne: à propos d´un cas
L´ostéoblastome est une tumeur osseuse primitive peu fréquente, sa localisation au niveau de la voûte du crâne est extrêmement rare. Nous rapportons un cas d´ostéoblastome de l´os pariétal droit chez une femme âgée de 46 ans ayant des antécédents de traumatisme crânien bénin. Elle a présenté de façon progressive une tuméfaction pariétale droite douloureuse non inflammatoire. Le scanner crânio-cérébral a montré une lésion osseuse hyperdense respectant la table interne de l´os pariètal droit. La patiente a bénéficié d´abord d´une biopsie puis d´une résection totale de la lésion osseuse avec une cranioplastie au ciment méthyl-méthacrylique. Les suites post-opératoires étaient simples. L´examen anatomo-pathologique a montré qu´il s´agissait d´un ostéoblastome sans signes de malignité. Nous discuterons, à travers notre premier cas d´ostéoblastome de la voûte du crâne et une revue de la littérature, sa présentation clinique, l´examen anatomo-pathologique, les aspects radiologiques, ainsi que la prise en charge de cette rare pathologie.
- 1 January 2020
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 36, 160
Open AccessOstéoblastome de l´os pariétal de la voute du crâne: à propos d´un cas
L´ostéoblastome est une tumeur osseuse primitive peu fréquente, sa localisation au niveau de la voûte du crâne est extrêmement rare. Nous rapportons un cas d´ostéoblastome de l´os pariétal droit chez une femme âgée de 46 ans ayant des antécédents de traumatisme crânien bénin. Elle a présenté de façon progressive une tuméfaction pariétale droite douloureuse non inflammatoire. Le scanner crânio-cérébral a montré une lésion osseuse hyperdense respectant la table interne de l´os pariètal droit. La patiente a bénéficié d´abord d´une biopsie puis d´une résection totale de la lésion osseuse avec une cranioplastie au ciment méthyl-méthacrylique. Les suites post-opératoires étaient simples. L´examen anatomo-pathologique a montré qu´il s´agissait d´un ostéoblastome sans signes de malignité. Nous discuterons, à travers notre premier cas d´ostéoblastome de la voûte du crâne et une revue de la littérature, sa présentation clinique, l´examen anatomo-pathologique, les aspects radiologiques, ainsi que la prise en charge de cette rare pathologie.
- Open Access
- 1 January 2019
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 33, 202
Epidural cavernous haemangioma during pregnancy: a case report and a literature review
Cavernous haemangiomas are benign vascular malformations that can locate in the central nervous system. The epidural spinal location remains unusual. Pregnancy is known to be a precipitating factor. The aim of this study is to review general aspects of these lesions and specific facts about their relationship to pregnancy. A 32-year-old full-term pregnant woman is managed during early labor for a progressive spinal cord compression syndrome. After delivery, exploration by a lumbar MRI found an epidural vascular dorsal mass. Surgical exploration and histopathological examination confirmed the diagnosis of epidural cavernous haemangioma. The patient achieved complete recovery after 1 month. Spinal cavernous haemangiomas are rare malformations. Specific mechanisms seems to be involved in their growth during pregnancy. Although clinical and radiological presentation are spectacular and misleading, the prognosis is generally good, and urgent surgical treatment during pregnancy is usually not indicated.
- 1 January 2019
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 33, 202
Open AccessEpidural cavernous haemangioma during pregnancy: a case report and a literature review
Cavernous haemangiomas are benign vascular malformations that can locate in the central nervous system. The epidural spinal location remains unusual. Pregnancy is known to be a precipitating factor. The aim of this study is to review general aspects of these lesions and specific facts about their relationship to pregnancy. A 32-year-old full-term pregnant woman is managed during early labor for a progressive spinal cord compression syndrome. After delivery, exploration by a lumbar MRI found an epidural vascular dorsal mass. Surgical exploration and histopathological examination confirmed the diagnosis of epidural cavernous haemangioma. The patient achieved complete recovery after 1 month. Spinal cavernous haemangiomas are rare malformations. Specific mechanisms seems to be involved in their growth during pregnancy. Although clinical and radiological presentation are spectacular and misleading, the prognosis is generally good, and urgent surgical treatment during pregnancy is usually not indicated.